Pfizer Receives Positive CHMP Opinion for Oncology Biosimilar, TRAZIMERA™ (trastuzumab)
Go back to Pfizer Receives Positive CHMP Opinion for Oncology Biosimilar, TRAZIMERA™ (trastuzumab)| Pfizer Inc. (NYSE: PFE) | Delayed: 28.72 +0.05 (0.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.67 | 52 Week High | $37.39 | |||
| Open | $28.62 | 52 Week Low | $28.25 | |||
| Day High | $28.87 | P/E | 17.41 | |||
| Day Low | $28.39 | EPS | $1.65 | |||
| Volume | 24,672,995 | |||||
